Episode Details

Back to Episodes
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA

Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA

Published 1 year ago
Description
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in axSpA. In this episode, our faculty discusses two papers: the first assesses switching to secukinumab or cycling with other TNF inhibitors, and the second investigates long-term safety of bimekizumab in adult patients with axSpA or PsA.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us